TheraNews
Subscribe

Archive summary Clinical & research

Study finds non-hallucinogenic psilocybin neural receptor: A novel target for treating depression and anxiety

Psilocybin—the psychedelic compound that occurs naturally in certain "magic" mushroom species—has been shown in trials to provide long-term treatment for depression and anxiety. But the chemical's hallucinogenic effects can make developing treatments expensive and pose significant risks to people li

Summary of reporting by medicalxpress 1 min read Markdown

Newsletter

The weekly digest

Weekly digest of US behavioral health policy and regulation, source-linked and practitioner-edited. Free; unsubscribe in one click.